2N L Harris,E S Jaffe,J Diebold,G Flandrin,H K Muller-Hermelink,J Vardiman,T A Lister,C D Bloomfield,张凤奎,郝玉书.世界卫生组织(WHO)造血与淋巴组织肿瘤分类方案:临床顾问委员会会议报告[J].白血病．淋巴瘤,2001,10(3):171-181. 被引量：20
1N L Harris,E S Jaffe,J Diebold,G Flandrin,H K Muller-Hermelink,J Vardiman,T A Lister,C D Bloomfield,张凤奎,郝玉书.世界卫生组织(WHO)造血与淋巴组织肿瘤分类方案:临床顾问委员会会议报告[J].白血病．淋巴瘤,2001,10(3):171-181. 被引量：20
4Melo JV. The diversity of bcr-abl fusion proteins and their relationship to leukemia phenotype. Blood, 1996,88: 2375-2384.
5Kwok S, Higuchi R . Avoiding false positives with PCR. Nature, 1989,339 : 237-238.
6Pane F, lntrieri M, Quintarelli C, et al. BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene, 2002,21:8652-8667.
7Perego RA, Costantini M, Comacchini G, et al. The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia. Eur J Cancer, 2000,36 : 1395-1401.
8Inokuchi K, Inoue T, Tojo A, et al. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphiapositive chronic myelogenous leukemia Blood, 1991 , 78 : 3125-3127.
9Saglio G, Pane F, Gottardi E, et al. Consistent amounts of acute leukemiaassociated P190^BCH/ABI transcripts are expressed by CML patients at diagnosis. Blood, 1996, 87:1075-1080.
10van Rhee F, Hochhaus A, Lin F, et al. P190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood, 1996, 87:5213-5217.
1Bench AJ, Erber WN, Scott MA. Molecular genetic analysis of haema- tological malignancies: I. Acute leukaemias and myeloproliferative dis- orders[J]. Clin Lab Haematol,2005,27(3) :148 - 171.
2Sacchi S, Russo D, Awisati G, et al. All-trans retionoic acid in he- matological malignancies, an update GER [ J ]. Haematologica, 1997, 82(1) :106 - 121.
3Byrd JC, Dodge RK, Carroll A, et al. Patients with t(8 ;21 ) (q22; q22 ) and acute myeloid leukemia have superior failure-fee and over- all survival when repetitive cycles of high-dose cytarabine are admin- istere [ J]. J Clin Oncol, 1999,17 ( 12 ) :3767 - 3775.
4Bench A J, Erber WN, Scott MA. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloprolifer- ative disorders[ J]. Clin Lab Haematol,2005,27 (3) :148 -171.
